{"schema_version":"secwatch.filing_event.v1","accession":"0000832101-24-000013","form_type":"8-K","ticker":"IEX","cik":"0000832101","company_name":"IDEX CORP /DE/","filed_at":"2024-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.103604+00:00","generated_at":"2026-06-03T10:38:54.959313+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IDEX Q1 sales $801M, -6% organic; adj. EPS $1.88 beats; FY guidance held","bullets":["Reported diluted EPS $1.60 (-13% YoY); adjusted EPS $1.88 (-10%), above expectations.","Organic sales -6% driven by HST segment (-13%); FMT -3%, FSDP +2%.","Operating cash flow $157M (+6%); free cash flow $137M (+13%).","FY2024 outlook: organic sales 0-2% growth; GAAP EPS $7.13-$7.43; adjusted $8.15-$8.45.","Q2 guidance: organic sales -2% to -3%; adjusted EPS $2.00-$2.05."],"urls":{"canonical":"https://secwatch.observer/filing/0000832101-24-000013","json":"https://secwatch.observer/filing/0000832101-24-000013.json","markdown":"https://secwatch.observer/filing/0000832101-24-000013.md","text":"https://secwatch.observer/filing/0000832101-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000013/0000832101-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000013/iex-20240423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T10:38:54.959313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3fee92ffebd7bf806f9b332466db51f77fbc34d0","claim":"IDEX CORP /DE/ reported full year 2024 results: EPS $7.13 - $7.43. Guidance reaffirmed.","evidence_excerpt":"Full year GAAP diluted EPS of $7.13 - $7.43 (adjusted diluted EPS of $8.15 - $8.45)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000013/0000832101-24-000013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2024"},{"label":"EPS","value":"$7.13 - $7.43"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"6a87aa11498b7ffcc1fec4c2103b33ead5cfb314","claim":"IDEX CORP /DE/ reported the three-month period ended March 31, 2024 results: revenue $801 million, net income $121.4 million, EPS $1.60.","evidence_excerpt":"First Quarter 2024 Highlights (All comparisons are against the first quarter of 2023 unless otherwise noted) • Sales of $801 million, down 5% overall and 6% organically, in line with expectations • Reported diluted EPS of $1.60, down 13%, and adjusted diluted EPS of $1.88, down 10%, exceeding first quarter expectations","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000013/0000832101-24-000013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three-month period ended March 31, 2024"},{"label":"Revenue","value":"$801 million"},{"label":"Net income","value":"$121.4 million"},{"label":"EPS","value":"$1.60"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c43f11df8028c5cecf91edf59bda91eead848899","claim":"IDEX CORP /DE/ reported second quarter 2024 results: EPS $1.75 - $1.80. Guidance initiated.","evidence_excerpt":"Second quarter GAAP diluted EPS of $1.75 - $1.80 (adjusted diluted EPS of $2.00 - $2.05)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832101/000083210124000013/0000832101-24-000013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter 2024"},{"label":"EPS","value":"$1.75 - $1.80"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}